The International Osteoporosis Foundation (IOF) announces an important editorial transition for Calcified Tissue International and Musculoskeletal Research. Effective 1 September 2026, Professor René Rizzoli will step down from his ...
The International Osteoporosis Foundation (IOF) is pleased to announce the appointment of Professor René Rizzoli as the next Editor-in-Chief for the European Office of Osteoporosis International and Archives of Osteoporosis ...
Calcified Tissue International & Musculoskeletal Research (CTI) enters an exciting new phase with important editorial and publishing developments. The journal welcomes Professor Roland Chapurlat as Associate Editor and announces the ...
A new position statement from the International Osteoporosis Foundation's (IOF) Committee of Scientific Advisors Fracture Working Group urges orthopaedic surgeons and bone health specialists to work together to assess and treat osteoporosis ...
Calcified Tissue International has published a special issue dedicated entirely to the dental enamel, one of the most remarkable and challenging tissues in the human body.
The special issue, titled ...
A new review published in Calcified Tissue International highlights major advances in understanding and preventing bone loss in people with rheumatoid arthritis (RA), showing that modern antirheumatic therapies can significantly ...
A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a comprehensive evaluation of the role of vitamin D in inflammatory rheumatic diseases ...
A new editorial in Osteoporosis International, “Beyond the fracture: coordinated action for bone health equity in Africa,” sets out a roadmap to address osteoporosis and fragility fractures ...
The International Osteoporosis Foundation (IOF) invites applications for the role of European Editor-in-Chief of Osteoporosis International. The appointment is commencing in Fall 2026. The application deadline is May 30, 2026 ...
A new international survey led by the International Osteoporosis Foundation reveals that adults living with hypophosphataemic osteomalacia (HO), a rare metabolic bone disorder, face a substantial and often under-recognised disease ...
A new paper published in Osteoporosis International describes the rigorous, user-centered development of “Build Better Bones,” a multilingual website created to support self-management for people living with osteoporosis ...
Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen production, AIs accelerate bone loss and increase ...